[No authors listed] (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874.
[2]
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310.
[3]
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546–1554.
[4]
World Health Organization (2008) Revised global burden of disease 2002 estimates. Available: http://www.who.int/healthinfo/bodgbd2002？revised/en/index.html. Accessed 18 July 2008.
[5]
Siddiqui S (2007) Not “surviving sepsis” in the developing countries. J Indian Med Assoc 105: 221.
[6]
Tanriover MD, Guven GS, Sen D, Unal S, Uzun O (2006) Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiol Infect 134: 315–322.
[7]
Frikha N, Mebazaa M, Mnif L, El Euch N, Abassi M, et al. (2005) [Septic shock in a Tunisian intensive care unit: Mortality and predictive factors. 100 cases]. Tunis Med 83: 320–325.
[8]
Smith C, Arregui LM, Promnitz DA, Feldman C (1991) Septic shock in the Intensive Care Unit, Hillbrow Hospital, Johannesburg. S Afr Med J 80: 181–184.
[9]
Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, et al. (2006) Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: Impact of intensive care unit performance and antimicrobial therapy. Croat Med J 47: 385–397.
[10]
Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, et al. (2004) Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 8: R251–R260.
[11]
White NJ (2003) Melioidosis. Lancet 361: 1715–1722.
[12]
Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, et al. (2000) Endemic melioidosis in tropical northern Australia: A 10-year prospective study and review of the literature. Clin Infect Dis 31: 981–986.
[13]
Cheng AC, Stephens DP, Anstey NM, Currie BJ (2004) Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis 38: 32–37.
[14]
Chan KP, Low JG, Raghuram J, Fook-Chong SM, Kurup A (2005) Clinical characteristics and outcome of severe melioidosis requiring intensive care. Chest 128: 3674–3678.
[15]
Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, et al. (2007) A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 45: 308–314.
[16]
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296–327.
[17]
Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis—Practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355: 1640–1642.
[18]
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, et al. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358: 125–139.
[19]
Sprung CL, Annane D, Keh D, Moreno R, Singer M, et al. (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358: 111–124.
[20]
World Bank (2008) Country classification. Available: go.worldbank.org/K2CKM78CC0. Accessed 18 July 2008.
[21]
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377.
[22]
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, et al. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589–1596.
[23]
Sazawal S, Black RE (2003) Effect of pneumonia case management on mortality in neonates, infants, and preschool children: A meta-analysis of community-based trials. Lancet Infect Dis 3: 547–556.
[24]
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538.
[25]
Carroll GC, Snyder JV (1982) Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 243: R131–R141.
[26]
Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM (1973) Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54: 421–432.
[27]
Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, et al. (1983) Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11: 839–850.
[28]
Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, et al. (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32: 1928–1948.
[29]
Hurtado FJ, Nin N (2006) The role of bundles in sepsis care. Crit Care Clin 22: 521–529. x.
[30]
Mock C, Visser L, Denno D, Maier R (1995) Aggressive fluid resuscitation and broad spectrum antibiotics decrease mortality from typhoid ileal perforation. Trop Doct 25: 115–117.
[31]
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, et al. (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247–2256.
[32]
Michell MW, Oliveira HM, Kinsky MP, Vaid SU, Herndon DN, et al. (2006) Enteral resuscitation of burn shock using World Health Organization oral rehydration solution: A potential solution for mass casualty care. J Burn Care Res 27: 819–825.
[33]
Nager AL, Wang VJ (2002) Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration. Pediatrics 109: 566–572.
[34]
Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, et al. (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227–242.
[35]
Weippl G (1979) [Infectious toxic hypotension—Effect and dosage of midodrine (author's transl)]. Padiatr Padol 14: 211–216.
[36]
Carlbom DJ, Rubenfeld GD (2007) Barriers to implementing protocol-based sepsis resuscitation in the emergency department—Results of a national survey. Crit Care Med 35: 2525–2532.
[37]
Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, et al. (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115: 529–535.
[38]
Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39–47.
[39]
Murdoch DR, Woods CW, Zimmerman MD, Dull PM, Belbase RH, et al. (2004) The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. Am J Trop Med Hyg 70: 670–675.
[40]
Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, et al. (1989) Melioidosis: A major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 159: 890–899.
[41]
Suttinont C, Losuwanaluk K, Niwatayakul K, Hoontrakul S, Intaranongpai W, et al. (2006) Causes of acute, undifferentiated, febrile illness in rural Thailand: Results of a prospective observational study. Ann Trop Med Parasitol 100: 363–370.
[42]
Phetsouvanh R, Phongmany S, Soukaloun D, Rasachak B, Soukhaseum V, et al. (2006) Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 75: 978–985.
Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA (2006) Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis 42: 377–382.
[45]
(1989) Melioidosis. Review of 686 cases and presentation of a new clinical classification. In: Punyagupta S, Sirisanthana T, Stapatayavong B, editors. Melioidosis. Bangkok: Bangkok Medical Publisher. pp. 217–229. editors.
[46]
White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, et al. (1989) Halving of mortality of severe melioidosis by ceftazidime. Lancet 2: 697–701.
[47]
Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, et al. (2007) Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 51: 819–825.
[48]
Kamolratanakul P, Dhanamun B, Thaithong S (1992) Human behavior in relation to selection of malaria treatment. Southeast Asian J Trop Med Public Health 23: 189–194.
[49]
Thamlikitkul V (1988) Antibiotic dispensing by drug store personnel in Bangkok, Thailand. J Antimicrob Chemother 21: 125–131.
[50]
Wertheimer AI, Chaney NM, Santella T (2003) Counterfeit pharmaceuticals: Current status and future projections. J Am Pharm Assoc 43: 710–717.
[51]
De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998) Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost 24: 367–379.
[52]
Nandi P, Wong KP, Wei WI, Ngan H, Ong GB (1980) Incidence of postoperative deep vein thrombosis in Hong Kong Chinese. Br J Surg 67: 251–253.
[53]
Lee HM, Suk KS, Moon SH, Kim DJ, Wang JM, et al. (2000) Deep vein thrombosis after major spinal surgery: Incidence in an East Asian population. Spine 25: 1827–1830.
[54]
Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, et al. (2007) The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai 90: 1342–1347.
[55]
Mannucci PM (2007) Thrombosis and bleeding disorders outside Western countries. J Thromb Haemost 5(Suppl 1): 68–72.
[56]
Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144: 124–130.
[57]
Hudson LD, Milberg JA, Anardi D, Maunder RJ (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151: 293–301.
[58]
Leong JR, Huang DT (2006) Ventilator-associated pneumonia. Surg Clin North Am 86: 1409–1429.
[59]
Jaimes F, De La Rosa G, Gomez E, Munera P, Ramirez J, et al. (2007) Incidence and risk factors for ventilator-associated pneumonia in a developing country: Where is the difference. Respir Med 101: 762–767.
[60]
[No authors listed] (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301–1308.
[61]
Hussain SF, Haqqee R, Iqbal J (2004) Non-invasive ventilation in the management of acute respiratory failure in Pakistan. Trop Doct 34: 238–239.
[62]
George IA, John G, John P, Peter JV, Christopher S (2007) An evaluation of the role of noninvasive positive pressure ventilation in the management of acute respiratory failure in a developing country. Indian J Med Sci 61: 495–504.
[63]
Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, et al. (2002) Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347: 895–902.
[64]
Maitland K, Akech S, Gwer S, Idro R, Fegan G, et al. (2007) Phase III trials required to resolve clinical equipoise over optimal fluid management in children with severe malaria. PLoS Clin Trials 2: e2. doi:10.1371/journal.pctr.0020002.
[65]
Idro R, Aketch S, Gwer S, Newton CR, Maitland K (2006) Research priorities in the management of severe malaria in children. Ann Trop Med Parasitol 100: 95–108.
[66]
Punjabi NH, Hoffman SL, Edman DC, Sukri N, Laughlin LW, et al. (1988) Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J 7: 598–600.
[67]
Rogerson SJ, Spooner VJ, Smith TA, Richens J (1991) Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 85: 113–116.
[68]
Hoffman SL, Punjabi NH, Kumala S, Moechtar MA, Pulungsih SP, et al. (1984) Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 310: 82–88.
[69]
Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–871.
[70]
Preiser J (2007) Intensive glycemic control in med-surg patients (European Glucontrol trial). Society of Critical Care Medicine 36th Critical Care Congress; 17–21 February 2007; Orlando, Florida, United States.
[71]
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709.
[72]
Abraham E, Laterre PF, Garg R, Levy H, Talwar D, et al. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353: 1332–1341.
[73]
Gove S (1997) Integrated management of childhood illness by outpatient health workers: Technical basis and overview. The WHO Working Group on Guidelines for Integrated Management of the Sick Child. Bull World Health Organ 75(Suppl 1): 7–24.
[74]
Duke T, Kelly J, Weber M, English M, Campbell H (2006) Hospital care for children in developing countries: Clinical guidelines and the need for evidence. J Trop Peds 52: 1–2.
[75]
Topley JM, Nkrumah FK (1987) Paediatric intensive care in Harare. Ann Trop Paediatr 7: 282–286.
[76]
Musgrove P (1999) Public spending on health care: How are different criteria related. Health Policy 47: 207–223.
[77]
Bhagwanjee S (2006) Critical care in Africa. Crit Care Clin 22: 433–438. viii.
[78]
Phraisuwan P, Whitney EA, Tharmaphornpilas P, Guharat S, Thongkamsamut S, et al. (2002) Leptospirosis: Skin wounds and control strategies, Thailand, 1999. Emerg Infect Dis 8: 1455–1459.
[79]
Snow RW, Gouws E, Omumbo J, Rapuoda B, Craig MH, et al. (1998) Models to predict the intensity of transmission: Applications to the burden of disease in Kenya. Trans R Soc Trop Med Hyg 92: 601–606.
[80]
Matsuda F, Ishimura S, Wagatsuma Y, Higashi T, Hayashi T, et al. (2008) Prediction of epidemic cholera due to O1 in children younger than 10 years using climate data in Bangladesh. Epidemiol Infect 136: 73–79.
[81]
Ali M, Wagatsuma Y, Emch M, Breiman RF (2003) Use of a geographic information system for defining spatial risk for dengue transmission in Bangladesh: Role for in an urban outbreak. Am J Trop Med Hyg 69: 634–640.
